newsfilter
← Latest News
GlobeNewswire·

RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges

  • Total company revenue increased 22.1% to $638.3 million in Q3 2026 from $522.9 million in Q3 2025.
  • Digital Health segment revenue grew 32.6% to $32.9 million in Q3 2026 from $24.8 million in Q3 2025.
  • Total company Adjusted EBITDA rose 23.8% to $105.0 million in Q3 2026 compared to $84.9 million in Q3 2025.
  • Digital Health segment Adjusted EBITDA decreased 11.8% to $3.0 million in Q3 2026 from $3.5 million in Q3 2025.
  • Adjusted EBITDA margin expanded to 16.5% in Q3 2026 from 16.2% in Q3 2025.
  • Adjusted diluted earnings per share were $0.30 in Q3 2026, up from $0.24 in Q3 2025.
  • Aggregate advanced imaging procedural volumes increased 19.9% in Q3 2026, with same-center volumes rising 8.9%.
  • Cash balance reached $750.6 million as of September 30, 2026, with a Net Debt to Adjusted EBITDA ratio of 1.66x.
  • RadNet raised full-year 2026 guidance for Imaging Center Revenue, Adjusted EBITDA, and Free Cash Flow.
  • Nine-month 2026 total revenue reached $1,836.6 million, a 23.1% increase from the prior year.
  • Nine-month 2026 Digital Health revenue increased 45.8% to $94.5 million.
  • Nine-month 2026 Adjusted EBITDA was $268.0 million, up 26.1% from the same period in 2025.
  • The company reported a net loss of $21.8 million for the first nine months of 2026, compared to a $18.1 million loss in 2025.
  • Advanced imaging mix increased to 30.6% of all procedures in Q3 2026 from 28.2% in Q3 2025.
  • RadNet announced a pending acquisition of ONRAD to expand capabilities in imaging centers and digital health solutions.
  • Conference call to discuss Q3 2026 results is scheduled for November 9, 2026, at 10:30 a.m. Eastern Time.
Company
RadNet, Inc.
Keywords
Nasdaq:RDNT, RadNet, Inc.